Jon C. Zimmerman

Jon C. Zimmerman

Directeur/Bestuurslid bij AIONX Antimicrobial Technologies, Inc.

Technology Services

Oorsprong van het eerstegraads netwerk van Jon C. Zimmerman

EntiteitType entiteitIndustrie
5
Holding Company Packaged Software 5

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Jon C. Zimmerman via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
JOHNSON & JOHNSON Pharmaceuticals: Major

James Hart

Corporate Officer/Principal

PROCTER & GAMBLE COMPANY Household/Personal Care

James Hart

Corporate Officer/Principal

ARTHROCARE CORPORATION Medical Specialties

James Hart

Corporate Officer/Principal

College/University

James Hart

Undergraduate Degree

Medical Specialties

Gary J. Shope

Chief Executive Officer

Pharmaceuticals: Major

Gautam Patel

Director/Board Member

Medical Specialties

James Hart

Founder

Biotechnology

Gautam Patel

Director/Board Member

Medical Specialties

James Hart

Director/Board Member

Medical Specialties

James Hart

Director/Board Member

Other Consumer Services

Gautam Patel

Director/Board Member

Medical Specialties

James Hart

President

Amherst College College/University

Seth R. Zimmerman

Undergraduate Degree

Claremont McKenna College College/University

Gautam Patel

Undergraduate Degree

DePauw University College/University

James Hart

Undergraduate Degree

Harvey Mudd College College/University

Gautam Patel

Undergraduate Degree

The University of Chicago College/University

Gautam Patel

Masters Business Admin

The Pennsylvania State University College/University

Ryan J. McCombie

Seth R. Zimmerman

Undergraduate Degree

Undergraduate Degree

London School of Economics & Political Science College/University

Gautam Patel

Graduate Degree

U.S. Army War College College/University

Ryan J. McCombie

Corporate Officer/Principal

Medical Specialties

James Hart

Sales & Marketing

Investment Managers

Gautam Patel

Corporate Officer/Principal

Investment Managers

Seth R. Zimmerman

Private Equity Analyst

United States Defense Intelligence Agency Sovereign

Ryan J. McCombie

Corporate Officer/Principal

United States Navy (District of Columbia) Sovereign

Ryan J. McCombie

Corporate Officer/Principal

Pharmaceuticals: Major

Gautam Patel

Director/Board Member

Pharmaceuticals: Other

James Hart

Chief Tech/Sci/R&D Officer

Investment Managers

Gautam Patel

Founder

Miscellaneous

Gautam Patel

Director/Board Member

Pharmaceuticals: Major

Gautam Patel

Director/Board Member

Investment Managers

Gautam Patel

Private Equity Investor

Tarsadia Foundation Investment Trusts/Mutual Funds

Gautam Patel

Director/Board Member

Pennsylvania State University College of Medicine College/University

James Hart

Doctorate Degree

Biotechnology

Gautam Patel

Director/Board Member

Services to the Health Industry

Gautam Patel

Director/Board Member

Pharmaceuticals: Major

Gautam Patel

Director/Board Member

Miscellaneous Commercial Services

Gautam Patel

Director/Board Member

Miscellaneous Commercial Services

Gautam Patel

Director/Board Member

Financial Conglomerates

Gautam Patel

Director/Board Member

Envisics LLC Miscellaneous

Gautam Patel

Director/Board Member

SPECTRUM BRANDS HOLDINGS, INC. Electronics/Appliances

Gautam Patel

Director/Board Member

Investment Managers

Gautam Patel

Founder

Miscellaneous Commercial Services

Gautam Patel

Director/Board Member

Johnson & Johnson Global Surgery Group

James Hart

Chief Tech/Sci/R&D Officer

CARMELL CORPORATION Biotechnology

James Hart

Chief Tech/Sci/R&D Officer

Battery Ventures /India/

Gautam Patel

Consultant / Advisor

AMNEAL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Gautam Patel

Director/Board Member

Statistieken

Internationaal

Verenigde Staten 41
Verenigd Koninkrijk 6
India 5

Sectoraal

Health Technology 19
Consumer Services 12
Finance 8
Miscellaneous 4
Commercial Services 4

Operationeel

Director/Board Member 23
Corporate Officer/Principal 9
Undergraduate Degree 7
President 3
Founder 3
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU